Takeaways from the Healthcare Businesswomen’s Association's 2019 Annual Conference.
The Healthcare Businesswomen’s Association (HBA) hosted its 2019 Annual Conference to a sell-out crowd in San Diego, November 11-12. More than 900 attendees gathered to network, share best practices, and acquire skills and solutions to help drive innovation and advance gender parity initiatives in the healthcare and life sciences workforce.
Conference participants took advantage of discussions focused on the “intersection of healthcare, leadership, and technology” conference theme. Educational sessions offered a mix of relevant topics from Beyond Bias: Awareness, Disruption, and Improvisation to Squirrel! Getting and Keeping the Attention of Today’s Listeners.
Keynote presentations featured speakers like Nancy Giordano, a leading futurist who shared insights on how current cultural and technological shifts are effecting business cultures. Author and mentoring expert Mary Stutts spoke to the compelling attestation of the power of women advising women.
This year’s HBA Woman of the Year Sharon Callahan-read her Pharm Exec profile here-was also on hand and led a panel discussion with JLABS’ Melinda Richter and TRG Healthcare’s Joe Wilkins talking about how non-traditional industry partners are working together in innovative ways to improve patient outcome.
Conference highlights also included the presentation of the 2019 ACE Awards recognizing industry initiatives that have proven to accelerate greater equity for women in the workplace.
Honorees Eli Lilly, EMD Serono and W2O took center stage to share how their programs have had a tremendous impact on their respective workplaces. Lilly’s Women’s Initiative for Leading at Lilly boosted the number of women in company management to 44%. EMD Serono’s Women in Leadership has more than doubled the number of women in senior leadership positions. And W2O’s innovative Your Fourth Trimester® program has been successful in helping moms transition back to work-retaining 96% of working moms after the birth of a child.
As HBA’s president and CEO Laurie Cooke shared, “These stellar initiatives merit recognition not only because they have significantly benefited the company’s female and male workforce, but just as importantly they are real and tangible examples of what is possible, to help women advance further, faster.”
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.